tetano
Editor, Senior Moderator
Diagn Microbiol Infect Dis. 2010 Sep 28. [Epub ahead of print]
Comparison of BinaxNOW Influenza A&B assay and real-time reverse transcription polymerase chain reaction for diagnosis of influenza A pandemic (H1N1) 2009 virus infection in adult patients.
Gimeno C, Bravo D, Ocete D, Tormo N, Navalpotro D, Costa E, de Lomas JG, Navarro D.
Microbiology Service, Centro de Diagn?stico Biom?dico, Consorcio Hospital General Universitario, Valencia 46014, Spain; Department of Microbiology, School of Medicine, Valencia 46010, Spain.
Abstract
The BinaxNOW Influenza A&B assay was evaluated for the diagnosis of influenza A pandemic (H1N1) 2009 virus infection in 354 adult patients. The sensitivity, specificity, and positive and negative predictive values were 32%, 100%, 100%, and 67%, respectively. The analytic sensitivity of the assay was log(10) 5.0 tissue culture infective dose (TCID)(50)/mL.
PMID: 20884157 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/20884157
Comparison of BinaxNOW Influenza A&B assay and real-time reverse transcription polymerase chain reaction for diagnosis of influenza A pandemic (H1N1) 2009 virus infection in adult patients.
Gimeno C, Bravo D, Ocete D, Tormo N, Navalpotro D, Costa E, de Lomas JG, Navarro D.
Microbiology Service, Centro de Diagn?stico Biom?dico, Consorcio Hospital General Universitario, Valencia 46014, Spain; Department of Microbiology, School of Medicine, Valencia 46010, Spain.
Abstract
The BinaxNOW Influenza A&B assay was evaluated for the diagnosis of influenza A pandemic (H1N1) 2009 virus infection in 354 adult patients. The sensitivity, specificity, and positive and negative predictive values were 32%, 100%, 100%, and 67%, respectively. The analytic sensitivity of the assay was log(10) 5.0 tissue culture infective dose (TCID)(50)/mL.
PMID: 20884157 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/20884157